Literature DB >> 20454928

Regulatory mechanisms of human and mouse telomerase reverse transcriptase gene transcription: distinct dependency on c-Myc.

Tsukasa Fujiki1, Miyako Udono, Keishi Kadooka, Shuntaro Yamashita, Takumi Miura, Sanetaka Shirahata, Yoshinori Katakura.   

Abstract

Telomerase-a complex ribonucleoprotein enzyme-synthesizes telomeric repeats to avoid telomere loss that accompanies cell division and chromosomal replication. Expression of telomerase is detectable in embryonic cells and cancer cells, but not in normal human cells. On the other hand, in mice, substantial expression of telomerase is detected in normal cells and tissues as well as in immortalized cells. These results suggest that the regulatory mechanisms of telomerase activity in humans and mice differ. Considering these results along with the fact that the expression of the telomerase reverse transcriptase (TERT) gene is a rate-limiting step for telomerase activity, we compared transcriptional regulatory mechanisms of both the species. A series of luciferase assays and RT-PCR analyses demonstrated that c-Myc, a dominant transactivator for human TERT (hTERT), is not involved in the regulation of mouse TERT (mTERT). These results suggest that distinct molecules and pathways are involved in the process of immortalization and tumorigenesis in human and mouse cells.

Entities:  

Year:  2010        PMID: 20454928      PMCID: PMC2978306          DOI: 10.1007/s10616-010-9276-y

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  18 in total

1.  Estrogen activates telomerase.

Authors:  S Kyo; M Takakura; T Kanaya; W Zhuo; K Fujimoto; Y Nishio; A Orimo; M Inoue
Journal:  Cancer Res       Date:  1999-12-01       Impact factor: 12.701

2.  Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells.

Authors:  D Xu; N Popov; M Hou; Q Wang; M Björkholm; A Gruber; A R Menkel; M Henriksson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

3.  Telomerase catalytic subunit homologs from fission yeast and human.

Authors:  T M Nakamura; G B Morin; K B Chapman; S L Weinrich; W H Andrews; J Lingner; C B Harley; T R Cech
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

4.  Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT).

Authors:  S Kyo; M Takakura; T Taira; T Kanaya; H Itoh; M Yutsudo; H Ariga; M Inoue
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

5.  Expression profile of the putative catalytic subunit of the telomerase gene.

Authors:  S Ramakrishnan; U Eppenberger; H Mueller; Y Shinkai; R Narayanan
Journal:  Cancer Res       Date:  1998-02-15       Impact factor: 12.701

6.  Function of AP-1 in transcription of the telomerase reverse transcriptase gene (TERT) in human and mouse cells.

Authors:  Masahiro Takakura; Satoru Kyo; Masaki Inoue; Woodring E Wright; Jerry W Shay
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

7.  Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT).

Authors:  M Wick; D Zubov; G Hagen
Journal:  Gene       Date:  1999-05-17       Impact factor: 3.688

8.  Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1.

Authors:  C Günes; S Lichtsteiner; A P Vasserot; C Englert
Journal:  Cancer Res       Date:  2000-04-15       Impact factor: 12.701

9.  Identification of Mad as a repressor of the human telomerase (hTERT) gene.

Authors:  S Oh; Y H Song; J Yim; T K Kim
Journal:  Oncogene       Date:  2000-03-09       Impact factor: 9.867

10.  Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation.

Authors:  R A Greenberg; R C O'Hagan; H Deng; Q Xiao; S R Hann; R R Adams; S Lichtsteiner; L Chin; G B Morin; R A DePinho
Journal:  Oncogene       Date:  1999-02-04       Impact factor: 9.867

View more
  6 in total

Review 1.  Telomerase at the intersection of cancer and aging.

Authors:  Bruno Bernardes de Jesus; Maria A Blasco
Journal:  Trends Genet       Date:  2013-07-19       Impact factor: 11.639

2.  Thymocytes maintain immune activity through telomere elongation in rats under hypoxic conditions.

Authors:  Yaping Wang; Zhen Zhao; Yingzhong Yang; Yanxia Zhao; Ri-Li Ge
Journal:  Exp Ther Med       Date:  2015-09-18       Impact factor: 2.447

3.  Telomerase activated thymidine analogue pro-drug is a new molecule targeting hepatocellular carcinoma.

Authors:  Mirko Tarocchi; Simone Polvani; Anna Julie Peired; Giada Marroncini; Massimo Calamante; Elisabetta Ceni; Daniela Rhodes; Tommaso Mello; Giuseppe Pieraccini; Alessandro Quattrone; Claudio Luchinat; Andrea Galli
Journal:  J Hepatol       Date:  2014-05-23       Impact factor: 25.083

Review 4.  TERT-Regulation and Roles in Cancer Formation.

Authors:  Marta Dratwa; Barbara Wysoczańska; Piotr Łacina; Tomasz Kubik; Katarzyna Bogunia-Kubik
Journal:  Front Immunol       Date:  2020-11-19       Impact factor: 7.561

Review 5.  Telomerase as a useful target in cancer fighting-the breast cancer case.

Authors:  Hanna Holysz; Natalia Lipinska; Anna Paszel-Jaworska; Blazej Rubis
Journal:  Tumour Biol       Date:  2013-04-05

6.  Telomere elongation protects heart and lung tissue cells from fatal damage in rats exposed to severe hypoxia.

Authors:  Yaping Wang; Zhen Zhao; Zhiyong Zhu; Pingying Li; Xiaolin Li; Xiaohong Xue; Jie Duo; Yingcai Ma
Journal:  J Physiol Anthropol       Date:  2018-02-17       Impact factor: 2.867

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.